Trial Profile
Phase II study of lucerastat for the treatment of lipid storage disorders
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 06 Oct 2017
Price :
$35
*
At a glance
- Drugs Lucerastat (Primary)
- Indications Lipid metabolism disorders
- Focus Therapeutic Use
- Sponsors Actelion Pharmaceuticals; Idorsia Pharmaceuticals
- 02 Mar 2015 New trial record